On behalf of the CVC and the Beyond 2018 (B2K18) educational program, we are pleased to share a Canadian Cardiovascular Society-accredited webinar series initiative that is being provided as an extension to the B2K18 symposium (held annually during the Canadian Cardiovascular Congress, most recently October 22, 2018).
Webinar 1 – Lipid Modifying Treatment Post-ACS
The first webinar in this series took place December 4, 2018 and covered the topic of Lipid Modifying Treatment Post-ACS. This webinar featured the symposium presentation by Dr. Gabriel Steg, along with a live interactive case study by Dr. Michael Heffernan, and an ODYSSEY OUTCOMES trial update (including data just presented at the American Heart Association Scientific Sessions) by Dr. Shaun Goodman.
Webinar 2 – Heart Failure with Diabetes and Renal Disease
The second webinar in this series, entitled “Heart Failure with Diabetes and Renal Disease”, took place on Tuesday, January 22, 2019, and featured a video presentation by Dr. Faiez Zannad and interactive patient case learning by Dr. Richard Choi.
Webinar 3 – Oral Antithrombotic Therapy in CAD
The 3rd webinar in this series, entitled “Oral Antithrombotic Therapy in CAD”, took place on Wednesday February 27, 2019, and featured the symposium presentation by Dr. John Eikelboom and a live interactive case study by Dr. Michael Heffernan.
A recording of webinar 3 will be available soon.